242 related articles for article (PubMed ID: 12737622)
1. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.
Lumb MJ; Birdsey GM; Danpure CJ
Biochem J; 2003 Aug; 374(Pt 1):79-87. PubMed ID: 12737622
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
Danpure CJ
J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
[TBL] [Abstract][Full Text] [Related]
3. Variable peroxisomal and mitochondrial targeting of alanine: glyoxylate aminotransferase in mammalian evolution and disease.
Danpure CJ
Bioessays; 1997 Apr; 19(4):317-26. PubMed ID: 9136629
[TBL] [Abstract][Full Text] [Related]
4. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.
Santana A; Salido E; Torres A; Shapiro LJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7277-82. PubMed ID: 12777626
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
Danpure CJ
Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
[TBL] [Abstract][Full Text] [Related]
6. Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease.
Danpure CJ; Lumb MJ; Birdsey GM; Zhang X
Biochim Biophys Acta; 2003 Apr; 1647(1-2):70-5. PubMed ID: 12686111
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.
Leiper JM; Oatey PB; Danpure CJ
J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378
[TBL] [Abstract][Full Text] [Related]
8. Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria.
Coulter-Mackie MB; Rumsby G; Applegarth DA; Toone JR
Mol Genet Metab; 2001 Nov; 74(3):314-21. PubMed ID: 11708860
[TBL] [Abstract][Full Text] [Related]
9. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.
Danpure CJ; Purdue PE; Fryer P; Griffiths S; Allsop J; Lumb MJ; Guttridge KM; Jennings PR; Scheinman JI; Mauer SM
Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040
[TBL] [Abstract][Full Text] [Related]
10. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
Lumb MJ; Danpure CJ
J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
Coulter-Mackie MB; Lian Q; Wong SG
Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
[TBL] [Abstract][Full Text] [Related]
12. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
Fargue S; Lewin J; Rumsby G; Danpure CJ
J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545
[TBL] [Abstract][Full Text] [Related]
13. Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant.
Cellini B; Lorenzetto A; Montioli R; Oppici E; Voltattorni CB
Biochimie; 2010 Dec; 92(12):1801-11. PubMed ID: 20713123
[TBL] [Abstract][Full Text] [Related]
14. Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1.
Motley A; Lumb MJ; Oatey PB; Jennings PR; De Zoysa PA; Wanders RJ; Tabak HF; Danpure CJ
J Cell Biol; 1995 Oct; 131(1):95-109. PubMed ID: 7559790
[TBL] [Abstract][Full Text] [Related]
15. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
Pey AL; Salido E; Sanchez-Ruiz JM
Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
[TBL] [Abstract][Full Text] [Related]
16. A unique molecular basis for enzyme mistargeting in primary hyperoxaluria type 1.
Leiper JM; Danpure CJ
Clin Chim Acta; 1997 Oct; 266(1):39-50. PubMed ID: 9435987
[TBL] [Abstract][Full Text] [Related]
17. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver.
Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T
Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700
[TBL] [Abstract][Full Text] [Related]
18. Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase.
Lumb MJ; Drake AF; Danpure CJ
J Biol Chem; 1999 Jul; 274(29):20587-96. PubMed ID: 10400689
[TBL] [Abstract][Full Text] [Related]
19. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
Williams EL; Acquaviva C; Amoroso A; Chevalier F; Coulter-Mackie M; Monico CG; Giachino D; Owen T; Robbiano A; Salido E; Waterham H; Rumsby G
Hum Mutat; 2009 Jun; 30(6):910-7. PubMed ID: 19479957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
